Premium
Letter: are infliximab and adalimumab similar for C rohn's disease in clinical practice?
Author(s) -
Tursi A.,
Elisei W.,
Picchio M.,
Penna A.
Publication year - 2013
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.12238
Subject(s) - medicine , infliximab , adalimumab , regimen , refractory (planetary science) , gastroenterology , population , referral , surgery , disease , physics , environmental health , astrobiology , family medicine
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom